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SUMMARY 
 
Separation of daughter cells during bacterial cell division requires splitting of the 
septal cross wall by peptidoglycan hydrolases. In Streptococcus pneumoniae, PcsB 
is predicted to perform this operation. Recent evidence shows that PcsB is 
recruited to the septum by the transmembrane FtsEX complex, and that this 
complex is required for cell division. However, PcsB lacks detectable catalytic 
activity in vitro, and while it has been proposed that FtsEX activates PcsB, evidence 
for this is lacking. Here we demonstrate that PcsB has muralytic activity, and report 
the crystal structure of full-length PcsB. The protein adopts a dimeric structure in 
which the V-shaped coiled-coil domain of each monomer acts as a pair of molecular 
tweezers locking the catalytic domain of each dimeric partner in an inactive 
configuration. This suggests that the release of the catalytic domains likely requires 
an ATP-driven conformational change in the FtsEX complex, conveyed towards the 
catalytic domains through coordinated movements of the coiled-coil domain. 
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 INTRODUCTION  
In order to divide, bacteria must synthesize a new septal cell wall, which must be split 
down the middle by one or more murein hydrolases to separate the resulting daughter 
cells. The precise molecular mechanism underlying this fundamental process is still poorly 
understood in most bacteria. In the present investigation, we have studied the septal cross 
wall-splitting mechanism in the Gram-positive bacterium Streptococcus pneumoniae. In 
addition to its important biological implications, this process might be worthy for 
therapeutic targeting since S. pneumoniae is a major human pathogen that has become 
increasingly resistant to antibiotics in recent decades 1. Thus, new drugs and new drug 
targets are urgently sought.  
The peptidoglycan (PG), the major constituent of the cell wall, is essential for 
bacterial survival. Its synthesis and turnover involve a number of enzymes that must 
function in a coordinated manner. During the last decade it has become clear that a two-
component regulatory system termed WalKR (also known as VicKR and YycGF) controls 
peptidoglycan metabolism in low G+C Gram-positive bacteria 2. Analysis of the WalKR 
regulons of Bacillus subtilis and Staphylococcus aureus have revealed their role in the 
control of the expression of a number of peptidoglycan hydrolases, some of which are 
involved in the separation of daughter cells 3,4. Similarly, genes encoding several putative 
and proven peptidoglycan hydrolases are part of the pneumococcal WalKR regulon 5,6. 
The product of one of these genes, PcsB (from protein required for cell wall separation of 
group B streptococcus), has been shown to be essential for viability in S. pneumoniae 
strains D39 and R6 7. PcsB is a secreted putative murein hydrolase that localizes to the 
septal area. It has been characterized to various degrees in S. pneumoniae 8,9, 
Streptococcus mutans (where it is called GbpB) 10, and Streptococcus agalactiae 11. In all 
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cases, it has been shown to be required for normal growth and cell division. Homologs of 
PcsB are present in all members of the genera Streptococcus and Lactococcus. 
Judging from its primary structure, PcsB consists of four parts: an N-terminal signal 
peptide, a coiled-coil (CC) domain containing putative leucine zipper motifs, an alanine-
rich linker region and a C-terminal cysteine, histidine-dependent 
amidohydrolase/peptidase (CHAP) domain. Despite the presence of this putative catalytic 
domain in the PcsB sequence, attempts to demonstrate hydrolytic activity of full-length 
PcsB have been unsuccessful 8,11,12. Recently it was discovered that PcsB interacts with 
the membrane-embedded protein FtsX through its N-terminal coiled-coil domain. FtsX has 
two extracellular loops, ECL1 and ECL2, which are involved in this interaction 13,14. At the 
cytoplasmic side of the membrane, FtsX, which has four transmembrane segments, 
interacts with FtsE. An increasing body of knowledge indicates that the FtsEX complex is 
an essential regulator of murein-hydrolase activity in Gram-positive as well as Gram-
negative bacteria 15. FtsE is an ATPase, and it is therefore believed that ATP hydrolysis 
drives a conformational change in the FtsEX/PcsB complex that activates PcsB.  
Recently PcsB has emerged as a leading candidate for a new-generation 
pneumococcal vaccine. Depending on the vaccine type, pneumococcal vaccine 
formulations in current use contain a mixture of 7-23 capsular polysaccharides, making 
them costly to produce and with limited serotype coverage. In addition, since there are at 
least 90 different capsular varieties, serotype replacement and capsular switching will 
eventually enable pneumococci to evade capsule-based vaccines. A promising alternative 
is the use of conserved nonpolysaccharide antigens 16. PcsB, which is a surface-exposed 
and exceptionally conserved protein (>99.5% identity) among clinical isolates of S. 
pneumoniae, has demonstrated its efficacy in lethal models of sepsis and pneumonia 17.   
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In the present report we show that depletion of PcsB in S. pneumoniae strain R6, 
inhibits daughter-cell separation without affecting the synthesis of new septal cross walls. 
We also provide strong evidence that the C-terminal CHAP domain of PcsB exhibits 
muralytic activity. Furthermore, the full-length pneumococcal PcsB protein was expressed, 
purified to homogeneity, crystallized and its structure determined. The structure displays a 
striking arrangement of the coiled-coil and catalytic domains, which associate forming a 
dimer through three-dimensional domain swapping. In solution the protein is present in a 
monomer-dimer equilibrium. Analysis of the structure, together with biochemical and 
biophysical characterization, have provided new insights into the catalytic mechanism of 
PcsB, revealing the regulatory role played by the PcsB-FtsEX complex during daughter 
cell separation. 
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RESULTS 
Effect of PcsB depletion on cross wall synthesis and cell separation  
In Gram-negative bacteria, synthesis and splitting of the new cross wall take place in close 
succession, leading to a gradual constriction of the whole bacterial cell that culminates in 
separation. On the other hand, in Gram-positives have been reported that the complete 
cross wall is synthesized before muralytic enzymes cleave it 18. To determine whether 
synthesis of the peptidoglycan cross wall is independent of cross-wall splitting we 
performed transmission-electron microscopy studies (TEM) of PcsB-depleted S. 
pneumoniae R6 cells. In intermediately depleted R6 cells, the first sign of PcsB deficiency 
is uncleaved cross walls. As seen in Supplementary Fig. 1, the original cell wall 
separating the first-generation daughter cells has not been cleaved, even though the 
second-generation daughter cells are separated by fully formed cross walls. In severely 
depleted cells, most new cross walls are misplaced. In these cells synthesis of the next 
septum can start anywhere from the internal surface of the cell and, in many cases, it 
grows at a skewed angle relative to the cell’s long axis. As shown in Supplementary Fig. 
1C, a new cross wall can even assemble on top of and at a right angle to an old cross wall. 
Together these results show three important facts about PcsB-depleted R6 cells: i) splitting 
of peptidoglycan cross walls are inhibited already in intermediately depleted cells, ii) the 
lack of PcsB does not inhibit the synthesis of new cross walls, and iii) strongly depleted 
cells lose their spatial orientation and initiates synthesis of new cross walls at random. The 
last effect may explain why PcsB is essential in the R6 strain.  For reasons unknown, 
some pneumococcal strains are able to survive without PcsB. Deletion of the pcsB gene in 
these strains gives rise to very sick cells with phenotypes that are highly similar to those 
depicted in Supplementary Fig. 1 17. 
Overall structure of PcsB 
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The crystal structure of the wild-type PcsB was solved at 2.5 Å resolution by the SAD 
technique (see Methods). The asymmetric unit of PcsB consists of two monomers 
arranged in a 164-Å long dimer (Fig. 1a). Each monomer is composed of three distinct 
regions: a coiled-coil domain (residues 41-266), a linker region (residues 267-278) and a 
CHAP domain (residues 279-392) (Fig. 1b and Supplementary Fig. 2). Structures of the 
two monomers show Cα backbone rmsd (root mean squared deviation) of 1.82 Å; as the 
domains are nearly identical (Cα backbone rmsd of 1.09 Å and 0.16 Å for CC and CHAP 
domains respectively) this value is due to a slight difference in modular arrangement 
between CC and CHAP domains for each monomer (Supplementary Fig. 3). Thus, 
hereafter, we limit our discussion to one PcsB molecule (Chain A). The whole structure 
can be roughly encased in an acute triangle of two long sides (~112 and ~118 Å) and a 
short side of ~66 Å. The CC domain is arranged in five helices, three long bent helices (α1, 
α3 and α4) composed of a large number of residues (66, 73 and 41 aa respectively) and 
two short ones (α2 and α5). The electron density was of good quality for all of them except 
for the short α2 that also has the highest B factors. The linker region is composed of an 
alanine-rich region and the sequence comprised of the stretch between Pro271 to Pro278 
(266-AAAPVRAKVRP-279). This region connects the end of the α5 helix of the CC domain 
with the globular catalytic CHAP domain. The electron density for the linker unequivocally 
defines the connection between the modules of one of the chains (Supplementary Fig. 4), 
while in the other the density is of less quality probably due to crystal contacts. The 
catalytic domain displays an α+β  papain-like amidase fold, with two α-helices (α1c and α2c) 
and an antiparallel β-sheet built up by  β1c to β4c (Fig. 1b). The N-terminal lobe (α1c-α2c) 
folds together with the C-terminal lobe, comprising the β-sheet, to build the active-site cleft 
(Fig. 1c). Similar to other amidases, the reactive cysteine of PcsB, Cys292, is positioned 
at the N-terminal end of α1c. 
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The architecture of the PcsB coiled-coil domain 
The extended CCPcsB is composed of residues arranged in a continuous helical 
arrangement. Only the first four residues (41-45) and those of the short turns do not follow 
this pattern.  All the helices within the CC domain are located in the same plane except for 
the α5 helix. The CC domain is a V-shaped molecule formed by helices α1-α3 on one side 
and by α4 and α5 on the other, making an angle of ~40º (Fig. 1b). A search for the closest 
structural homologues of CCPcsB with the DALI server 19 reveals that no similar structure for 
the complete CC has been reported previously. High structural homology is, however, 
found between the antiparallel α1α3 bundle of the CC domain and the human inter-SH2 
domains of p85β and p85α, the regulatory subunits of phosphatidylinositol-4,5-
biphosphate 3-kinase (PI3K), the tower domain of the Lys-specific histone demethylase, 
the molecular chaperone prefoldin and the structures of coiled-coil domains from type III 
secretion system translocators (Supplementary Fig. 5). 
Remarkably, inter-helix interactions in the CCPcsB differ depending on the helices in 
question: interactions between α1 and α3 are mainly mediated by hydrogen bonds and by 
the hydrophobic interactions of residues forming a leucine zipper (Fig. 1d), in contrast, α3 
interacts with α4 through salt links and the hydrophobic contribution is less relevant, as a 
consequence of the presence of less bulky alanine residues (all the Ala-rich regions, 
except that of the linker, are located in α4) (Fig. 1d). Interestingly, Tyr238 is inserted at the 
bottom of the V-shaped conformation. Together with long-chain charged residues it opens 
the cavity in which the catalytic domain of the other paired monomer is located (Fig. 1d). 
 
The catalytic machinery of the CHAP domain of PcsB 
 9 
A search for proteins structurally related to the catalytic domain of PcsB was performed 
with the DALI server 19. Papain-like proteins such as the Staphylococcus saprophyticus 
CHAP domain protein, the catalytic domain of endolysin PlyCA and the type VI amidase 
effector Tse1 from Pseudomonas aeruginosa, were found to be among the most closely 
related 3D structures (Supplementary Fig. 6a). 
Papain-like hydrolytic enzymes form covalent intermediates with their substrates during 
the course of the reaction. A reactive cysteine acts as a catalytic nucleophile, promoted by 
the side chain of a histidine. The His-imidazole ring is further hydrogen-bonded to a third 
catalytic residue, usually an Asp or Asn. The Cys-His-Asp/Asn catalytic triad is positioned 
by the common structural core; the cysteine is located at the N terminus of the helix, and 
the histidine and the Asp/Asn are provided by the β-sheet and linking loops 20. Sequence 
analysis suggested that Cys292, His343 and Asn366 are the catalytic residues in this triad. 
Mutations in the first two residues (Cys292Ala and His343Ala) are not tolerated in PcsB, 
whereas that of Asn366Ala is 7. Our crystal structure indicates that Asn366 is far from the 
Cys292 (Fig. 1c) while the Glu360 is hydrogen bonded to His343 and superimposes with 
the Asn175 from the catalytic triad of the papain (Supplementary Fig. 6b). Therefore, the 
catalytic triad is comprised of Cys292, His343 and Glu360 (Fig. 1c). The corresponding 
triad positions are also seen in the secreted CHAP domain from S. saprophyticus 21 and 
were shown to be the proteolytic triad in pyroglutamyl peptidases, a family of cysteine 
peptidases 22. Remarkably, a strong network of salt-bridge and hydrogen-bond interactions 
is observed around the active site of PcsB (Fig. 1c). Besides the expected hydrogen-
bonds between the catalytic triad, Glu360 is making salt-bridge interactions with both 
His372 and Arg373, and the last with Glu383. These interactions could modulate the PcsB 
activity depending on the protonation state of the corresponding amino acids. 
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Substrate binding in PcsB 
The active site of PcsB is partially occluded by the presence of the α3 helix from the 
dimeric partner (Fig. 1a), a fact that provides interesting implications for the regulatory role 
of the coiled-coil domain in the PcsB dimer (see discussion below). Among the 
peptidoglycan papain amidases, some, as for instance Spr from E. coli, have a closed 
active-site architecture with active-site loops blocking the active site entrance. Others like 
Tse1 from P. aeruginosa present an exposed active site 23 (Supplementary Fig. 7). 
Similar to Tse1, CHAPPcsB has an open active site with loops L1-L3 (Fig. 1c and 
Supplementary Fig. 7) protruding outwards, creating a large groove ~31 Å long and ~7 Å 
wide. The active site of one monomer, chain A, showed an entrapped polyethylene glycol 
molecule, presumably mimicking binding of the substrate (Fig. 2a and Supplementary Fig. 
8). This open active site, however, is partially occluded due to the dimeric arrangement. 
Very interestingly, the distance between the putative glycan strands is greater than 30 Å 24. 
Consequently, the active site of PcsB could get access to the peptide bridges that 
interconnect the glycan strands in the peptidoglycan sacculus. 
All attempts to obtain crystals of a complex between PcsB and peptidoglycan analogues 
failed, very likely due to the occlusion created by the dimer arrangement. To gain insight 
into the substrate recognition by PcsB, we performed docking calculations with GOLD 25 
using a peptide stem fragment, L-Ala-D-isoGln-L-Lys-D-Ala, present in pneumococcal 
peptidoglycan. The top scoring positions nicely fit the polyethylene glycol molecule found 
at the active site of the crystal structure (Fig. 2a and 2b) and place the scissile bond 
between isoGln and L-Lys close to the catalytic Cys292 and His343. The ligand is strongly 
stabilized by many hydrogen bonds and salt links with residues in the active site 
(Supplementary Fig. 9). Remarkably, a very similar conformation for the substrate (L-Ala-
D-Glu-mDAP) was found in Tse1 from P. aeruginosa 23 where mDAP is present in place of 
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L-Lys. It has been shown that Tse1 exhibits a strong preference for the mDAP-type 23. Our 
docking calculations reveal the presence of an acidic patch in the PcsB active site formed 
by Asp338 and Glu383 (Fig. 2b and Supplementary Fig. 9), responsible of stabilization of 
L-Lys in the crosslinked peptidoglycan. This patch doesn’t exist in Tse1, and consequently 
provides an explanation for the different substrate specificities of the two PG amidases. 
 
CHAPPcsB displays murein hydrolase activity  
To investigate whether full-length PcsB has muralytic activity we performed zymography 
with purified recombinant PcsB and pneumococcal cells mixed into the separating SDS-
PAGE gel as substrate. Consistent with the results reported by others 8,11,12, no muralytic 
activity was detected. Next, we expressed only the C-terminal CHAP domain of PcsB. For 
purification purposes, a 6xHis tag was attached to the N-terminal end of the domain (see 
Methods). Zymography analysis performed with various amounts of the CHAPPcsB protein 
revealed distinct clearing zones in the opaque gel at the expected migration positions (Fig. 
3a and 3b). As a negative control, we expressed a mutated version of the CHAP domain 
(His-CHAPC292A) in which the catalytic cysteine was substituted with an alanine. No 
clearing zones were observed when the same amounts of the CHAPPcsB(C292A) mutant 
protein was subjected to zymography (Fig. 3a and 3b). Together, these results provide 
strong evidence that the catalytic domain has muralytic activity and further support the 
open conformation observed in the crystal structure of CHAPPcsB. In order to identify the 
exact bond split by PcsB, purified peptidoglycan was treated with CHAPPcsB in solution. 
Subsequent analysis of the digest by reverse phase HPLC, however, did not reveal any 
cleavage products. Thus, it remains for future studies to determine the cleavage specificity 
of PcsB. 
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Modular arrangement and oligomerization in PcsB 
A dimeric arrangement of PcsB molecules was found in the crystal structure (Fig. 1a). This 
dimer is formed by three-dimensional domain swapping 26, in which both monomers 
exchange their catalytic domains in a similar way to that originally described for the dimeric 
structure of diphtheria toxin 27. The dimer places both catalytic domains in the middle with 
their active sites oriented in opposite directions, and with the CC domain extending 
outwards on the same axis in a 164 Å long dimer. Analysis of the PcsB dimer by the PISA 
server 28, gave a high value for the complex formation significance score (0.915) and 
indicated that the buried area upon assembly formation is 7040 Å2. The calculated free 
energy of assembly dissociation (ΔGdiss) is 26.1 kcal/M. The ΔGdiss corresponds to the free 
energy difference between dissociated and associated states. Positive values 
of ΔGdiss indicate that an external driving force should be applied in order to dissociate the 
assembly. Consequently, the PcsB assembly is predicted to be thermodynamically stable. 
The V-shaped CC domain of one monomer clamps the CHAP domain of the other in a 
narrow cavity. All the α helices of the CC domain, except for the α2 helix, are involved in 
the interaction with the CHAP domain. While there are few hydrogen bonds and no salt 
links between the two domains (Supplementary Table 1), about three-quarters of the 
CC/CHAP interactions are van der Waals contacts, most of which involve exposed 
hydrophobic side chains (Supplementary Fig. 10 and Supplementary Table 1). 
In agreement with crystallographic results, analytical ultracentrifugation experiments over a 
broad range of protein concentrations (0.1-8.0 mg/ml) revealed that the protein exists as 
an equilibrium mixture of dimers and monomers in solution, with dimer favored at higher 
protein concentrations (over 4 mg/ml) and monomer at low concentrations 
(Supplementary Fig. 11). The monomer-dimer equilibrium presents an estimated Kd of 90 
µM. Interestingly, while the experimental sedimentation coefficients for the dimer are 
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compatible with that calculated for the crystallographic dimeric structure, those for the 
monomer are better described by a PcsB molecule with the CHAP domain inserted in its 
own CC domain rather than the protein monomer observed in the asymmetric unit of our 
crystal (Supplementary Fig. 11). 
We explored whether the arrangement in the crystal is representative of PcsB in solution 
using small angle X-ray scattering (SAXS). The overall molecular parameters derived from 
the scattering data are given in Supplementary Table 2. The scattering profiles at five 
different concentrations (0.29-9.40 mg/ml) (Fig. 4 and Supplementary Fig. 12) indicate 
the presence of a monomer-dimer equilibrium, being the monomer more abundant at lower 
concentrations whereas the dimer is the predominant form at higher concentrations. A 
molecular mass of 61±6 kDa was deduced for the dimer, which is comparable to the 
expected dimer mass of 78 kDa (Supplementary Table 2). The radius of gyration (Rg) 
and the maximum dimension (Dmax) with values of 45±3 Å and 168±7 Å respectively, 
indicate a rather extended dimeric assembly in agreement with the dimensions observed 
in the crystal structure (Dmax of 164 Å, see Fig. 1a). The ab initio models generated with 
DAMMIF and DAMMIN without symmetry constrains produced rather elongated shapes of 
PcsB at high concentration. Rigid-body modeling was performed using the dimer found in 
the crystal structure, showing that the envelope encases the main core of the dimer (Fig. 
4c). It is worth to note that the α2 regions that present the highest B factors in the crystal 
structure are not observed in the SAXS envelope of the dimer. At low concentrations 
(0.29-1.18 mg/ml) PcsB appeared mostly as a monomer with a molecular mass and Rg 
between 35±4/44±4 kDa and 35±6/41±6 Å respectively (Supplementary Table 2). The 
Dmax for monomers (Supplementary Table 2) were also compatible with their associated 
crystallographic monomer (122 Å). Rigid-body modeling of the PcsB monomer extracted 
from the crystallographic dimer inside the SAXS envelope, fits well the elongated CC 
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domain (colored in orange in Fig. 4b) but not the linker or the CHAP domain (colored in 
blue in Fig. 4b) indicating that a single molecular conformation alone does not represent 
the experimental data fittingly. Remarkably, if the catalytic domain is replaced with the one 
corresponding to its dimeric partner (colored in red in Fig. 4b) the model perfectly fits the 
SAXS envelope. Therefore two relevant points can be derived from this analysis; first, in 
solution the monomeric PcsB present an inactive conformation with the CHAP domain 
inserted in its own CC domain, and second, the PcsB dimer is generated by the three-
dimensional domain swapping of their catalytic domains. 
 
Evidence that PcsB murolytic activity is regulated by its modular arrangement 
We have previously characterized a murein hydrolase termed LytF 29, which is 
produced by Streptococcus gordonii strain Challis during the competent state. LytF 
consists of an N-terminal cell wall binding domain and a C-terminal CHAP domain. The C-
terminal CHAP domains of PcsB and LytF are the same size and 70% identical, while their 
N-terminal domains are unrelated. Considering that CHAPPcsB and CHAPLytF are highly 
similar (Supplementary Fig. 13), we wondered whether CHAPPcsB would become active if 
fused to the N-terminal domain of LytF. To test this idea we replaced the CHAP domain of 
LytF with the CHAP domain of PcsB. The resulting LytF-CHAPPcsB chimera was expressed 
in pneumococcal cells from the ComS*-inducible PcomX promoter 30. Extracts from 
pneumococcal cultures grown in the presence of 0, 0.01, 0.2 and 2 µM ComS* were 
subjected to zymography with S. gordonii cells incorporated in the separating gel (Fig. 3c 
and 3d). The analysis revealed a clearing zone corresponding to the expected molecular 
weight of LytF-CHAPPcsB in the sample induced with 2 µM ComS*. The fact that the LytF-
CHAPPcsB chimera gives rise to clearing zones in gels containing S. gordonii cells as 
substrate shows that the structure and composition of the peptide-cross bridges of S. 
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pneumoniae and S. gordonii must be similar. Available data indicates that the 
pentapeptide stem L-Ala-D-isoGln-L-Lys-D-Ala-D-Ala is the same in the two species. In S. 
pneumoniae interpeptide bridges are either absent or predominantly L-Lys-L-Ser-L-Ala-D-
Ala, while they are predominantly L-Lys-L-Ala-L-Ala-D-Ala in S. gordonii 42 31. 
 To further verify that the function of PcsB depends on the muralytic activity of its 
CHAP domain, we constructed a chimera in which the CHAP domain of PcsB was 
replaced by the corresponding domain of LytF. LytF, which is produced by S. gordonii cells 
during the competent state, lyses susceptible streptococcal cells by disrupting their cell 
wall 29.  The gene encoding this PcsB-CHAPLytF chimera was inserted into the native pcsB 
locus in a strain that expressed the wild-type PcsB ectopically from the PcomX promoter.  
Next, the wild-type gene was deleted from the ectopic locus giving rise to strain SPH250. 
Surprisingly, the SPH250 strain was viable. A homology model for the PcsB-CHAPLytF 
chimera was constructed (Supplementary Fig. 13). This model indicates that the main 
determinants for catalytic activity and substrate recognition were conserved between both 
CHAP domains. Despite some of the interactions stabilizing CC and CHAP domains in 
PcsB (such as a poli-Ala region) could be disturbed in the chimera (Supplementary Fig. 
13) the strain SPH250 is viable. Its doubling time of 45 min was somewhat longer than the 
35 min generation time of the parental strain. In addition, inspection of the SPH250 
cultures by light microscopy revealed some enlarged misshapen cells, morphological 
changes reminiscent of those seen in pneumococcal cells that have been subjected to 
light PcsB depletion (Supplementary Fig 14). Together, these results provide strong 
evidence that the CHAP domain of PcsB has muralytic activity which is regulated by the 
CC domain.  
 
DISCUSSION 
 16 
The crystal structure of the peptidoglycan amidase PcsB reveals a surprising 
arrangement of its different domains. The coiled-coil domain is a unique V-shaped 
molecule built by three long bent α helices and two short ones. A flexible and extended 11-
aa linker connects the coiled-coil domain with the catalytic CHAP domain. Remarkably, the 
crystal structure of the full-length PcsB is a dimer formed by three-dimensional domain 
swapping in which the entire catalytic domain of one monomer is inserted in the internal 
cavity of the coiled-coil domain of the other (Fig. 1a and Fig. 2c), a pattern that is also 
observed for the monomer in solution as deduce from AUC and SAXS experiments. The 
PISA server further confirmed the stability of this dimer formation, as well as by analytical 
ultracentrifugation and by SAXS experiments. In this unique oligomeric arrangement the 
coiled-coil domain of one monomer acts as molecular tweezers clamping the catalytic 
domain of its dimeric partner. The implications of this arrangement are profound; active 
sites are partially occluded (roughly half of the active-site groove) by the α3 helix of the 
partner resulting in an inactive dimer. This point was confirmed by our experiments with 
the CHAPPcsB domain and a LytF-CHAPPcsB chimera in which the CHAPLytF domain of the 
LytF fratricine was replaced by the closely related CHAPPcsB domain of PcsB.  When 
separated from the CC domain the CHAPPcsB domain turned out to be active on its own in 
zymography assays. Similarly, when fused to the cell wall binding domain of LytF, the 
CHAP domain of PcsB displayed muralytic activity (Fig. 3). In contrast, muralytic activity 
was not observed with the full-length PcsB protein. The functional homology of the 
CHAPPcsB and CHAPLytF domains was demonstrated by showing that replacement of PcsB 
in strain R6 with a chimera consisting of the CC domain of PcsB and the CHAP domain of 
LytF gave rise to viable R6 cells. 
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The role of the CC domain, however, goes beyond its inhibitory function. The 
structural framework provided by the CC domain is also required for activation of PcsB, i.e. 
for cross-wall splitting and daughter-cell separation. It has been reported that a 
temperature sensitive (Ts) mutant containing two amino-acid changes (L79S and L218P, 
R6 strain numbering) in the CC domain of PcsB showed mild or severe defects in cell 
morphology and division at 32 °C or 41.4 °C, respectively 13. At the non-permissive 
temperature, the double mutant formed spherical cells that phenocopied the defect caused 
by severe depletion of PcsB 13. The three-dimensional structure of PcsB shows that these 
mutations are located in the leucine zipper regions and are involved in the interaction 
between α1 and α3 (Leu 79) and in the interaction between α4 and α3 (Leu218) 
(Supplementary Fig.15). Thus, the alteration in the CC architecture caused by these 
amino acid changes probably perturbs the activation mechanism of PcsB and locks the 
mutant protein in an inactive state, although we can not discard other possibilities such as 
the mutant is unstable and degraded, or that mutations in the CC domain could alter the 
length of the protein or its orientation relative to the cytoplasmic membrane.  
The conserved FtsEX complex recently emerged as a major regulator of PG 
hydrolysis during bacterial cell division 13,15,32. FtsEX is essential or conditionally essential 
in a great variety of bacterial species 14,33. FtsEX structurally resembles an ABC 
transporter 34 , but recent studies indicate that FtsEX acts as a signal transduction system 
rather than as a transporter of an unknown substrate 33. The 3D structure of PcsB provides 
clues to how regulation/activation by the FtsEX complex can take place (Fig. 5). The 
dimeric arrangement of PcsB precludes any lytic activity unless the CHAP domain is 
released, in a controlled way, from the CC domain. To release the CHAP domain, the 
“molecular tweezers”, which consists of α1-α3 on one side and α4-α5 on the other, must 
be opened on both sides. Previous studies involving Ts and suppressor mutants of PcsB 
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and FtsX, respectively, revealed mutations in the large (ECL1) and small (ECL2) 
extracellular loops of FtsX which indicate that the FtsX-PcsB interaction occurs between 
these loops and the CC domain of PcsB13,14. The Ts mutations in CCPcsB are located just in 
the middle of α1 and α3 helices and at the base of α4 helix (Supplementary Fig.15), while 
the connecting regions in FtsX involve the distal portion of the ECL1 and ECL2 loops 14. 
These results point to a specific interaction between the FtsX loops and both sides of the 
“molecular tweezers”. The energy required for the coordinated movement of α helices in 
the CCPcsB domain is in all likelihood produced by hydrolysis of ATP by FtsE. In agreement 
with this, it has been shown that the conserved amino acids in the ATP binding site of FtsE 
are essential for pneumococcal growth, supporting the idea that ATPase activity by FtsE is 
required for FtsEX→PcsB signaling and coordination of cell separation 14. Once released, 
the catalytic domain would not require further opening of the active-site loops. We have 
demonstrated that CHAP alone exhibits hydrolytic activity and presents a pre-formed 31-Å 
groove that can accommodate the cross-linked peptide stems (Fig. 5c). Our docking 
calculations allowed us to map the different subsites of substrate-peptide recognition for 
PcsB. Especially relevant is the presence of an acidic patch that could explain PcsB’s 
specificity for L-Lys containing stem-peptides (Fig. 2b and Supplementary Fig. 9). 
Further studies on hydrolytic activity of PcsB are however required to precisely identify the 
cleavage site of this enzyme. 
 
Our TEM studies of intermediately and severely PcsB-depleted cells show that the 
synthesis of new cross walls continues unimpeded in the absence of PcsB, suggesting 
that the cross wall splitting machinery operates independently of the septal peptidoglycan 
synthesis machinery. What controls the activity of the cross wall splitting machinery to 
ensure that it acts at the right time and place? As discussed above, evidence strongly 
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supports that ATP hydrolysis by FtsE provides the energy needed to activate PcsB.  
However, as ATP is abundant in the cytoplasm throughout the cell cycle, the availability of 
this nucleotide cannot be a factor that controls splitting of the cross wall. In principle, the 
level of PcsB, FtsX FtsE or possibly other hitherto unknown members of the cell wall 
splitting machinery could be tightly regulated in a cell cycle dependent manner, but so far 
no evidence of such regulation has been reported. In our view the unusual dimeric 
structure of PcsB is a striking characteristic that must serve a critical function in the in vivo 
regulation of this murein hydrolase. A pertinent question is: Why is the dimer linear with 
CHAP domains in the middle and CC domains at each end?  An intriguing possibility is 
that dimers form in vivo when a monomer (in the inactive configuration observed in the 
analytical ultracentrifugation and SAXS experiments) from each of the daughter cells meet 
in the middle of the cross wall. As shown in Fig. 5 this implies that the PcsB dimer extends 
across the cross wall and interacts with FtsEX complexes at both ends. Measurements 
from TEM micrographs showed that the thickness of the pneumococcal cross wall is in the 
range of 17-25 nm. It is reasonable to assume that the periplasmic part of FtsX will add a 
few nanometers to each end of the 16.4 nm long PcsB dimer. Consequently, the estimated 
thickness of the cross wall is consistent with the model depicted in Fig. 5b. The appealing 
feature of this model is that splitting of the shared cross wall involves active participation of 
both daughter cells. Presumably, this introduces an additional level of control in the 
division process. If PcsB can only function as a dimer, it means that it can only be active in 
cleaving cross walls and not ordinary cell walls. Only cross walls have membranes on both 
sides that make it possible to insert PcsB from the compartment of each daughter cell so 
that the molecules will meet in the middle and dimerize. This would represent an ingenious 
control mechanism. Due to the net-like polymeric structure of peptidoglycan, the mobility of 
PcsB dimers is probably restricted. Thus, it is likely that PcsB, which is a moderately 
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abundant protein in the pneumococcal cell (about ~5000 monomers per cell,12), only acts 
locally and is then discarded. This is supported by the fact that relatively large amounts of 
PcsB are released to the medium during growth 12. In sum, our results indicate that the 
unique modular structure and dimeric organization of PcsB have evolved to allow precise 
splitting of the septum during cell division, while avoiding damage to other parts of the 
peptidoglycan sacculus. 
 
 
Accession codes.  
Atomic coordinates and structure factors for native PcsB have been deposited in the 
Protein Data Bank with accession code 4CGK.  
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FIGURE LEGENDS 
 
Figure 1 Three-dimensional structure of PcsB. (a) Representation of the PcsB dimer 
showing the molecular surface for monomer A (coiled-coil domain colored in pink and 
catalytic domain in orange) and the monomer B as a ribbon representation (coiled-coil 
domain colored in light blue and catalytic domain in dark blue). Arrows indicate the active 
sites. (b) General structure of PcsB monomer. Coiled-coil domain (pink) is formed by five 
helices. An eleven-residues linker region (dark red) connects to the catalytic CHAP domain. 
The CHAP domain is built by N-lobe (colored in blue) and C-lobe (colored in orange), the 
different secondary structural elements are labeled. (c) Active site of PcsB showing the 
catalytic residues (Cys292, His343 and Glu360) and the interaction network around the 
triad. Relevant loops in the active site (L1, L2 and L3) are labeled. The salt bridge 
interaction (E291-R367) connecting the L1 and L3 loops is also depicted. The previously 
predicted catalytic Asn366 is far from the active site and oriented outward. (d) Interactions 
connecting α1, α3 and α4 of the coiled-coil domain (pink cartoon). Leu and Ile residues 
involved in hydrophobic interactions are depicted as green sticks. Residues involved in salt 
links, and Tyr238, are drawn as pink capped sticks. The Ala-rich regions are colored in 
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magenta. The CHAP domain of the dimeric partner is represented as blue cartoon and the 
catalytic Cys292’ as yellow sticks. 
 
Figure 2. The active site of PcsB. (a) Molecular surface representation of the CHAP 
domain of PcsB. The catalytic Cys292 is colored in yellow. The PEG molecule attached to 
the active site is represented as capped sticks. The length of the active-site groove is 
indicated by an arrow. (b) Electrostatic potential on the CHAPPcsB molecular surface with 
the peptide L-Ala-D-isoGln-L-Lys-D-Ala docked in the active site. An acidic patch (colored 
in red) stabilizes L-Lys. (c) Domain interactions between the coiled coil domain in chain A 
(CC-A) with the CHAP domain of chain B (CHAP-B). Color code as in Fig.1. White arrow 
indicates, as in panel (a), the active-site groove. 
 
 
Figure 3. Zymogram analysis demonstrating the peptidoglycan-hydrolyzing activity 
of His-CHAPPcsB and the LytF-CHAPPcsB chimera (a) Muralytic activity of His-CHAPPcsB. 
Different amounts of purified His-CHAPPcsB and its C292A mutated counterpart (3.75, 7.5 
and 15 µg indicated on top) were separated in an SDS-PAGE gel containing RH14 cells as 
substrate. The light bands are clearing zones showing degradation of the peptidoglycan of 
the RH14 cells incorporated in the SDS-PAGE gel. (b) A parallel gel without RH14 cells 
was stained with Coomassie Blue to visualize the purified His-CHAPPcsB and His-
CHAPPcsB(C292A) recombinant proteins loaded onto the gel in panel (a). (c) Cartoon 
depicting the domain composition of PcsB and LytF, and the chimera (LytF-CHAPPcsB and 
PcsB-CHAPLytF) constructed by swapping the domains of the parental proteins. The LytF-
CHAPPcsB chimera was used in the zymogram analysis displayed below in panel d. The 
gene encoding the PcsB-CHAPLytF chimera was incorporated into the genome of S. 
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pneumoniae strain R6 to determine whether the chimeric protein was able to replace the 
essential PcsB wild type protein (see result section for details). (d) Zymogram analysis. 
Lanes: MW, molecular weight marker; LytF (-), extracts of S. gordonii cells; LytF (+), 
extracts of competence induced S. gordonii cells producing LytF; LytF-CHAPPcsB (0-2), 
extracts of pneumococci expressing increasing amounts of LytF-CHAPPcsB chimera from 
the ComS*-inducible PComX promoter 30. ComS* is a 8 aa synthetic peptide that is added to 
the growth medium to induce transcription of genes inserted behind the PComX promoter. 
Maximum expression is reached at 2 µM ComS* (see text for details). The light bands in 
lanes containing cell extracts are clearing zones that result from degradation of the 
peptidoglycan sacculus of S. gordonii cells that have been incorporated in the SDS-PAGE 
separating gel. Left arrow: clearing zone corresponding to wild type LytF. Right arrow: 
clearing zone corresponding to the LytF-CHAPPcsB chimera. 
 
Figure 4. Arrangement of PcsB in solution by SAXS. (a) SAXS experimental scattering 
curves (dots) and theoretical scattering computed from the models (smooth curves) at 
different concentrations of PcsB. The data for different concentrations were offset vertically 
for clarity. a.u. arbitrary units. (b) Rigid-body overlaying of the ab initio determined SAXS 
envelope and the PcsB crystallographic monomer.  The elongated CC domain (colored in 
orange) fits into the envelope but not the linker or the CHAP domain (colored in blue). In 
red, a model where the catalytic domain belongs to the dimeric partner, that perfectly fits 
the SAXS envelope. (c) Rigid-body fitting of the PcsB crystallographic dimer inside the 
SAXS envelope. The region around the α2 helix presents the highest B factors in the 
crystal structure, and is not observed in the SAXS envelope of the dimer. 
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Figure 5. Activation and regulation in PcsB. (a) Proposed model for regulation of 
hydrolytic activity of PcsB. The inactive dimer is located at the septum by FtsX (1). The 
ATPase activity of FtsE induces an allosteric change on PcsB through FtsX producing the 
release of the CHAP domains (2). The catalytic domains start the PG hydrolysis (3). (b) 
Possible spatial location of PcsB dimers (yellow and magenta ribbon) on the 
pneumococcal septum. The structure of the FtsEX complex resembles that of an ABC 
transporter (PDB code 2ONJ, is coloured in white ribbons representing FtsEX). (c) Model 
of the cross-linked PG chains (capped sticks) bound at the molecular surface of the 
CHAPPcsB (magenta). The peptide substrate used in docking calculations is highlighted 
(with C atoms in yellow, N atoms in blue and O atoms in red).  
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METHODS 
Bacterial growth and transformation 
Strains of Escherichia coli were grown in Luria Bertani medium at 37 or 28°C with shaking 
in the presence of 100 µg/ml ampicillin when appropriate. E. coli was transformed by heat 
shock as described by Sambrook and Russell 35. S. pneumoniae strain R6 and S. gordonii 
strain Challis were grown without shaking at 37°C in C medium 36 and Todd-Hewitt 
medium (Difco), respectively. Construction of S. pneumoniae mutants was performed by 
natural transformation. Briefly, pneumococcal cultures were cultivated at 37°C until they 
reached OD550 = 0.05-0.1. Then, transforming DNA and 250 ng/ml of synthetic 
competence stimulating peptide (CSP1) were added. After further incubation at 37°C for 
120 min, transformants were selected on Todd-Hewitt plates containing the appropriate 
antibiotic; kanamycin (400 µg/ml) or streptomycin (200 µg/ml). 
Expression and purification of mature PcsB 
PcsB was purified by using the tandem affinity tag called CHiC-tag as previously described 
by Stamsås et al. 37 followed by ion exchange chromatography. In brief, pcsB fused to the 
CHiC-tag by overlap extension PCR 38 was cloned into the expression vector pRSET A 
(Invitrogen) resulting in pGS01 37. E. coli BL21 (DE3) (Invitrogen) containing the plasmid 
pGS01 (strain gs32, see Supplementary Table 3) was grown at 37°C with shaking. When 
reaching OD600 = 0.3 expression of CHiC-fused PcsB was induced by adding isopropyl-β-
D-thiogalactopyranoside (IPTG) to a final concentration of 0.1 mM. After incubation for 4 h 
at 28°C cells from two litres of cell culture were harvested at 5000 x g and resuspended in 
40 ml 10 mM Tris-HCl (pH 7.4) containing 100 mM NaCl. The cells were lysed by adding 
lysozyme to a final concentration of 1 mg/ml. CHiC-PcsB was purified from the soluble 
protein fraction by DEAE-cellulose affinity chromatography as described by Sanchez-
Puelles et al 39. The CHiC-tag was then separated from PcsB by digestion with AcTEV 
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Protease (Invitrogen) at 30°C for 3 h. The free CHiC-tag, undigested CHiC-PcsB and 
AcTEV™ Protease, all of which contains a 6xHis tag, were removed by Ni(2+)-NTA affinity 
chromatography. The flow through which contained PcsB in 10 mM Tris-HCl (pH7.4) was 
then bound on to an anion exchanger (Sepharose Q, GE Healthcare) and eluted by 
gradually increasing the NaCl concentration from 0 to 500 mM in a 25 ml gradient. The 
flow-rate was set to 1 ml/min. The fractions containing >99% pure PcsB were pooled and 
concentrated by using Amicon Ultra-15 Centrifugal Filter Units (Millipore). 
 
Cloning and production of SeMet-PcsB 
A SeMet derivative of PcsB was produced in order to solve the phase problem associated 
with the structure determination of native PcsB. Since mature PcsB only contains two 
methionines per 365 residues (M140 and M150), we introduced two additional methionines 
by replacing the residues Q180 and L250 with M. Methionine codons were introduced at 
codon 180 and 250 by overlap extension PCR 38. For the CAA180 to ATG180 (Q180M) 
substitution, base pairs 535-1179 of pcsB were amplified using the forward primer ds85 
and the T7 revers primer producing PCR product 1 (Primers are listed in Supplementary 
Table 4). The region corresponding to base pairs 1-559 of pcsB fused 5’ to the CHiC-tag 
was amplified using the T7 forward primer and revers primer ds86 producing PCR product 
2. The plasmid pGS01 37 served as template in both reactions. Since primer ds85 is 
complementary to primer ds86, PCR product 1 and 2 were fused in an overlap extension 
PCR by using the flanking primers T7 forward and T7 revers generating PCR product 3. 
To introduce the additional CTT250 to ATG250 (L250M) substitution, base pairs 748-1179 
of pcsB were amplified using forward primer ds79 and T7 revers primer producing PCR 
product 4. Similarly region 1-773 of pcsB fused 5’ to the CHiC-tag was amplified using the 
T7 forward primer and revers primer ds80 to generate PCR product 5. PCR product 3 was 
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used as template in both reactions. PCR fragment 4 and 5 were fused in an overlap 
extension PCR using the T7 forward and T7 revers primers. This generated PCR fragment 
6 which contained a Q180M and L250M version of PcsB fused N-terminally to the CHiC-
tag. This mutated version of PcsB will be referred to as PcsBmut. Fragment 6 was cleaved 
with XbaI and EcoRI and ligated immediately downstream of the T7lac promoter in pRSET 
A giving rise to plasmid pGS214.  
For production of SeMet-PcsBmut, E. coli BL21 (DE3) harboring pGS214 (strain 
ds122, see Supplementary Table 3) was grown in M9 minimal medium containing 0.4% 
glucose 35 and 50 mM choline chloride. Choline was supplemented to M9 to improve the 
solubility of CHiC-PcsBmut. At OD600 = 0.3 methionine production in E. coli BL21 (DE3) was 
blocked by adding the following cocktail of amino acids: L-lysine (0.1 mg/ml), L-
phenylalanine (0.1 mg/ml), L-threonine (0.1 mg/ml), L-isoleucine (0.05 mg/ml), L-leucine 
(0.05 mg/ml) and L-valine (0.05 mg/ml). After 10 min the production of selenomethionine 
derivatized CHiC-PcsBmut was induced by adding a final concentration of 0.1 mM IPTG 
and 0.05 mg selenomethionine (Acros Organics) per ml growth medium. The cells were 
grown at 28°C for 4 h before SeMet derivatized CHiC-PcsBmut was purified as described 
above for native PcsB.  
 
Construction of pcsB-CHAPlytF, lytF-CHAPpcsB, His-CHAPPcsB, and His-CHAPPcsB(C292A) 
To construct the pcsB-CHAPlytF chimeric gene, pneumococcal pcsB without its CHAP 
encoding part (bp 1-858) was amplified using the primer pair 216/52 and genomic DNA 
from strain RH1 40 as template. The CHAP encoding part of lytF (bp 1260-1578) was 
amplified using the primer pair 53/217 and genomic DNA from S. gordonii (Challis) as 
template. These two fragments were fused by overlap extension PCR using the primer pair 
216/217 producing the fragment pcsB-CHAPlytF. Next, ~1000-bp fragments corresponding 
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to the 5’ and 3’ flanking regions of pcsB were amplified with the primer pairs 37/218 and 
219/38, respectively. Genomic DNA from the RH1 strain was used as template. By overlap 
extension PCR the 5’ flanking region was fused to the 5’ end of the pcsB-CHAPlytF gene 
using the primer pair 37/217. Similarly, the 3’ flanking region was fused to the 3’ end of 
pcsB-CHAPlytF using the primer pair 216/38. Finally, these two fragments were fused using 
the primers 37 and 38. 
  To test if PcsB-CHAPlytF could substitute for wild type PcsB in S. pneumoniae we 
wanted to replace the native pcsB gene with the chimeric pcsB-CHAPlytF gene. As pcsB is 
an essential gene in S. pneumoniae R6, an extra copy of the wild type gene had to be 
expressed ectopically before the native pcsB gene could be removed and replaced by a 
Janus cassette 41. For ectopic expression of pcsB we employed the R6 derivative SPH131, 
which has the ComRS expression/depletion system integrated in its genome 30. First, the 
pcsB gene was amplified with the primers 35 and 36 and DNA from strain RH1 as 
template. Next, fragments corresponding to the ~1000-bp upstream and downstream 
regions of the Janus cassette in strain SPH131 were amplified using the primer pairs 
khb31/khb36 and khb33/khb34, respectively. Then, by the use of overlap extension PCR 
with the primers khb31 and 36, the pcsB fragment was fused to the upstream fragment. 
Similarly, the pcsB fragment was fused to the downstream fragment by using the primers 
35 and khb34. Finally these two fragments were fused using the primer pair khb31/khb34. 
By replacing the Janus cassette in SPH131 with the resulting PCR product strain SPH246 
was generated.  
Before the pcsB-CHAPlytF gene could be introduced into the native pcsB locus, the 
native pcsB gene was replaced with the Janus cassette. The Janus cassette was amplified 
with the primers Kan484.F and RpsL41.R and genomic DNA from strain RH426 42 as 
template. Fragments (~1000 bp) corresponding to the 5’ and 3’ regions of the native pcsB 
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gene was amplified using the primer pairs 37/39 and 40/38, respectively. DNA from strain 
RH1 was used as template. The resulting fragments were then fused to the Janus cassette 
in separate PCR reactions. The 5’ flanking region was fused to the Janus cassette using 
the primers 37 and RpsL41.R, while the 3’ flanking region was fused to the Janus cassette 
with the primers Kan484.F and 38. Finally, these two fragments were fused together using 
the primers 37 and 38. By transforming strain SPH246 with a PCR fragment corresponding 
to the Janus cassette flanked by the upstream and downstream regions of the pcsB gene, 
strain SPH247 was obtained. Transformants of SPH247 was grown in the presence 1 µM 
ComS* to drive ectopic expression of PcsB. Next, the Janus cassette in SPH247 was 
replaced with the pcsB-CHAPlytF fragment described above, giving rise to strain SPH248. 
For removal of the ectopically expressed copy of WT pcsB in strain SPH248, this gene and 
its PcomX promoter was replaced by a Janus cassette. Genomic DNA from strain SPH154 
43, which contains a Janus cassette inserted in the ectopic locus, served as template to 
amplify a PCR fragment consisting of the Janus cassette plus ~1000 bp flanking regions. 
The PCR reaction was carried out with the primers khb31 and khb34. The resulting 
fragment was transformed into strain SPH248, generating strain SPH249. Finally, the 
Janus cassette was removed by transforming strain SPH249 with a fragment containing 
only the flanking regions of the Janus cassette. The 5’ and the 3’ region of the Janus 
cassette were amplified using the primer pairs khb31/khb32 and 154/khb34, respectively. 
DNA from SPH154 served as template. These two fragments were fused by overlap 
extension PCR using the primer pair khb31/khb34. The resulting fragment was 
transformed into strain SPH249, giving rise to strain SPH250. 
To construct lytF-CHAPpcsB the region (bp 76-1332) encoding the cell wall binding 
domain of LytF (without its 25 aa leader sequence) was amplified using the primer pair 
ds95/ds96 and DNA from S. gordonii strain Challis as template. The CHAP-encoding 
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region of PcsB (bp 859-1179) was amplified using the primer pair ds97/ds98 and DNA 
from S. pneumoniae RH1 as template. These two fragments were fused in an overlap 
extension PCR with the flanking primers ds95 and ds98 resulting in a lytF-CHAPpcsB 
chimera. LytF-CHAPPcsB was expressed in S. pneumoniae by using the ComRS system 
described by Berg and co-workers 30. The 5’ and 3’ regions of the Janus cassette in strain 
SPH131 (see above) were amplified by the primer pairs khb31/khb36 and khb33/khb34, 
respectively, and then fused to the 5’ and 3’ ends of the lytF-CHAPpcsB fragment by overlap 
extension PCR using the primers khb31 and khb34. The resulting fragment was 
transformed into strain SPH131, replacing the Janus cassette and giving rise to strain 
SPH252.  
To construct His-CHAPPcsB we amplified the CHAP encoding part of pcsB using the 
primers ds147 and T7 revers primer and the plasmid pGS01 37 as template. The C292A 
mutated version of CHAPPcsB was amplified using the same primers but with genomic DNA 
from SPH258 as template. Primer ds147 contains a 6xHis encoding part. The PCR 
products were cleaved with XbaI and EcoRI and ligated in to pRSET A immediately 
downstream of the T7lac promoter. The resulting plasmids were transformed into E. coli 
BL21 (DE3) giving rise to strain ds179 and ds189. 
 
Zymogram analysis 
The muralytic activity of LytF-CHAPPcsB, His-CHAPPcsB and His-CHAPPcsB(C292A) was 
examined in zymogram gels. For LytF-CHAPPcsB strain SPH252 was grown in the 
presence of 0, 0.01, 0.2 and 2 µM ComS* inducer for 1 h to drive LytF-CHAPPcsB 
expression. Competence induced S. gordonii (Challis) was used as control for native LytF 
activity 29. The cells were collected at OD550 = 0.25 by centrifugation and lysed in SDS 
sample buffer. Total protein extracts were separated by SDS-PAGE using a 12% 
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separation gel containing S. gordonii (Challis) cells as substrate. The cell substrate was 
collected from a 300 ml S. gordonii (Challis) culture at OD550 = 0.3. The cells were 
suspended in 1.25 ml separation gel buffer (1.5 M Tris-HCl, pH 8.8) and heat inactivated at 
95°C for 10 min before they were mixed into the resolving gel. After gel electrophoresis the 
gel was washed two times for 30 min in distilled water before protein refolding was initiated 
by submerging the gels in 50 mM NaCl, 20 mM MgCl2, 0.5% Triton X-100, and 20 mM 
Tris-HCl, pH 7.4. The gels were incubated in refolding buffer until muralytic activity was 
observed as clear bands in the opaque gel.  
Similarly, the activity of His-CHAPPcsB and its C292A mutated counterpart were 
examined in zymogram gels containing S. pneumoniae strain RH14 as substrate. His-
CHAPPcsB and His-CHAPPcsB(C292A) were expressed in E. coli strain ds179 and ds189 
respectively by adding a final concentration of 0.1 mM IPTG at OD600 = 0.3 followed by 
incubation at 28°C for 4 h. A volume of 500 ml induced ds179 cells were collected by 
centrifugation at 5000 x g for 5 min. The cells were then resuspended in 5 ml of 10 mM 
Tris-HCl, pH 7.4 containing 100 mM NaCl. The cells were lysed by adding lysozyme to a 
final concentration of 1 mg/ml followed by 10 min at 37°C. His-CHAPPcsB and His-
CHAPPcsB(C292A) were purified from the soluble protein fraction by using Protino® Ni-
TED150 (Macherey-Nagel) columns as described by the manufacturer. The purified 
proteins were then separated by SDS-PAGE in 13% zymogram gels before the gels were 
incubated in refolding buffer. 
 
Transmission electron microscopy. 
SPH247 cells were grown to an OD550 = 0.3 in the presence of 1 µM ComS*, harvested by 
centrifugation, and washed once in C medium to remove excess ComS*. To start depletion 
of pcsB the washed cells were resuspended in C medium containing 0 µM ComS* to an 
 32 
OD550 = 0.025. Cells were collected for transmission electron microscopy 1 h before their 
growth rate was affected by PcsB starvation and 45 min after the cell growth was severely 
inhibited by pcsB depletion. Cells were fixed by mixing cell culture and fix solution (2% 
paraformaldehyde [v/v] and 2.5% glutardialdehyde [w/v] in 0.1 M sodium cacodylat buffer 
pH 7.4) in a 1:1 ratio. After incubation at room temperature for 1 h, the cells were fixed 
overnight at 4°C. The fixed cells were washed three times in sodium cacodylat buffer (0.1 
M, pH 7.4). 
For transmission electron microscopy, fixed cells were post-fixed for 1 h at room 
temperature using 1% OsO4 (w/v) and 1.5% K3[Fe(CN)6] (w/v) dissolved in dH2O. 
Following three washing steps in dH2O (3x10 min), cells were pre-stained for 30 min using 
1% uranyl acetate. Next, cells were washed for 3 x 10 min in water, and dehydrated with a 
gradient series of ethanol comprising 10 min sequential incubations in 70%, 90% and 
100% ethanol. Finally the cells were stepwise infiltrated in LR White resin as follows: LR 
White resin : EtOH in ratios 1:3 for 30 min, 1:1 overnight, 3:1 for 4 h, and finally 100% LR 
White resin overnight followed by embedding in 100% LR White resin at 60°C overnight. 
Thin sections were cut with a diamond knife mounted on an ultra-microtome (LEICA, EM 
UC 6). The sections were counterstained with 1% KMnO4 for 10 min. After staining, the 
grids were washed thoroughly in dH2O. The sections were examined in a FEI MORGAGNI 
268 electron microscope. 
 
PcsB Crystallization. Crystals of native PcsB were obtained using the sitting-drop vapor 
diffusion method at 4ºC. Crystals grew in 2 µl droplets formed by mixing 1 µl of protein 
solution at 10 mg/ml (buffered in 20 mM Tris-HCl pH 7.5) and 1 µl of precipitant solution 
formed by 12% (v/v) polyethylenglycol 4000, 0.1M Hepes pH 7.5, 0.2M Magnesium 
Acetate in 1:1 volume ratio drops supplemented with 115,38 mM Guanidinium chloride and 
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33.5 mM N-octyl-β-D-Glucopiranoside. Crystals belong to the P3121 hexagonal space 
group (a= b= 125.8 Å, c=126.6 Å). PcsB Se-Met derivative crystals were obtained in the 
same way as the native PcsB crystals but replacing magnesium acetate by zinc acetate in 
the reservoir solution. Se-Met derivative crystals belong to the P3121 hexagonal space 
group (a= b= 127.2 Å, c=126.3 Å). 
 
X-ray data collection and structural determination. Crystals were harvested in a proper 
reservoir solution supplemented with 23% ethylene glycol, mounted into nylon loops, and 
flash-cooled in liquid nitrogen. Native and SAD experiments were carried out on beamline 
ID29 at the European Synchrotron Radiation Facility (ESRF) (Grenoble, France). All X-ray 
data sets were processed and scaled with XDS 44 and Aimless 45 respectively. PcsB 
structure was solved by SAD technique. Due to the low content of methionine residues (2 
Met residues) in the wt PcsB sequence, four different constructions were produced having 
two additional methionine residues. Among them only the PcsB-Q180M-L250M construct 
could be expressed in the presence of SeMet, purified and crystallized. PcsB-Q180M-
L250M crystals diffracted up to at 2.71 Å resolution. The initial selenium sites were located 
with SHELX 46 using the HKL2MAP GUI 47 and refined within AUTOSHARP 48. Solvent 
flattening was calculated with Parrot 49 followed by density modification with Pirate 
program 50. Initial model was obtained with Buccaneer 51 followed by manual modelling 
with COOT 52. Two monomers were found in the asymmetric unit yielding a Matthews’s 
coefficient of 3.97 Å3/Da and a solvent content of 69.07%. All X-ray data sets presented 
anisotropy, the best of the native PcsB being collected at 2.55 Å resolution. The PcsB-
SeMet derivative structure was used as initial model in the molecular replacement method 
using Phaser 53. Structure of native PcsB was subjected to alternate cycles of refinement 
with Refmac5 54 and COOT. Geometry of the final models was checked with 
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MOLPROBITY 55. In all cases, the good quality of all electron density maps allowed 
modeling the most part of the polypeptide chain, ligands and solvent molecules (see Table 
1). The first 40 amino acids from the N-terminal tail were disordered and were not visible in 
the structure and the short helix α2 presented a poor electron density especially in one of 
the monomers. In the crystal structure of the native PcsB the electron density map clearly 
defines a polyethylene glycol moiety attached to the active site of chain B. The figures 
were generated by using PyMol (Molecular Graphics System, Version 1.5.0.4 Schrödinger, 
LLC.). 
 
Docking calculations 
The structure of the pneumococcal peptidoglycan peptide stem fragment L-Ala-D-isoGln-
L-Lys-D-Ala was modeled using pymol. Charges assignment and optimization was 
carried in chimera 56. Molecular docking was carried using GOLD (Genetic Optimization 
for Ligand Docking) software 25 , using the genetic algorithm (GA). The PEG ligand found 
in the crystal structure was used as starting point for cavity detection. For each of the 25 
independent GA runs, a maximum number of 100,000 GA operations were performed on 
a set of five groups with a population size of 100 individuals. Default cut-off values of 2.5 
? (dH-X) for hydrogen bonds and 4.0 ? for Van Deer Waals distance were employed. 
When the top three solutions attained RMSD values within 1.5 ?, GA docking was 
terminated. The RMSD values for the docking calculations are based on the RMSD 
matrix of the ranked solutions. Best-ranked solutions were always among the first 10 GA 
runs, and the conformation of molecules based on the best fitness score was further 
analyzed. 
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Analytical Ultracentrifugation. 
Sedimentation velocity was used in combination with sedimentation equilibrium to 
determine the association state of protein PcsB over a broad range of concentrations 
(0.1-8.0 mg/ml). Sedimentation velocity runs were carried out at 48,000 rpm and 20 °C in 
an XL-I analytical ultracentrifuge (Beckman-Coulter Inc.) equipped with UV-VIS and 
Raleigh interference detection system, using an An50Ti rotor and 3 and 12 mm double 
sector centerpieces (sample in the range of 0.1-1.0 mg/ml were loaded in normal 12 mm 
centerpiece and samples in the range of 2.0-8.0 mg/ml in narrow 3 mm centerpieces). 
The sedimentation coefficient distributions were calculated by least squares boundary 
modeling of sedimentation velocity data using the c(s) method 57 as implemented in the 
SEDFIT program. Calculated s values were corrected to standard conditions (water, 20 
°C, and infinite dilution) using the SEDNTERP program 58 and the concentration 
dependence of s, to get the corresponding standard s values. Short column (21-85 µl, 
depending of the centerpieces) equilibrium runs were carried out at multiple speeds 
(8,000, 12,000, and 15,000 rpm) and the corresponding scans were measured at the 
appropriate wavelength. Whole cell apparent weight-average buoyant molecular weight 
of the protein samples were determined by fitting a single species model to the 
experimental data using the HeteroAnalysis	   program 59. The corresponding protein 
molecular weights were calculated from the experimental buoyant values using 0.722 
cm3/g as the protein partial specific volume. Several models of self-association were 
globally fitted to multiple sedimentation equilibrium using the HeteroAnalysis program. 
To assign the most probable structure of the main protein species present, the standard 
s-values experimentally obtained were compared with the s-values determined for given 
structural models using the shell-model calculation implemented in HYDROPRO 60.  
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SAXS experiments. 
SAXS data were collected at the EMBL beamline BM29 at the ESRF (Grenoble, France), 
using a robotic sample changer, from six sample solutions of PcsB at concentrations 
ranging from 0.29-9.40 mg ml-1 in 10 mM Tris-HCl pH 7.4 and 5% glycerol at 277 K. Data 
were recorded using a photon-counting Pilatus 1M pixel detector (DECTRIS, Switzerland) 
at a sample–detector distance of 2.7 m and a wavelength of λ = 1 Å. The scattering 
intensity I(q) was recorded in a range of the momentum transfer 0.01 < q < 0.6 Å−1 
(where q = 4π sinθ/λ, and 2θ is the scattering angle). Sample solutions were circulated in 
a thermostatic flow mode during the measurement to minimize radiation damage effects. 
Ten frames of 1 s exposures were collected for each sample, normalized to the 
transmitted intensity, and subsequently averaged using AUTOSUB. In PRIMUS, the 
forward scattering I(0) and the radii of gyration Rg were estimated using the Guinier 
approximation I(q) = I(0) exp(−(qRg)2/3) with qRg < 1.3. These parameters were also 
computed from the entire scattering patterns using the indirect transform package GNOM, 
providing also the pair-distance distribution function P(r), from which the maximum 
particle dimension, Dmax, was estimated. The molecular weight was calculated from 
excluded volume of the hydrated particle (the Porod volume, Vp). The ab initio modeling 
programs DAMMIN and DAMMIF were used for low-resolution shape generation, and 10 
models were calculated in the slow mode, and averaged with DAMAVER, which also 
provides a value of normalized spatial discrepancy (NSD) representing a measure of 
similarity among different models. The theoretical profile from the high-resolution 
structure of PcsB was computed with CRYSOL. The ab initio model was superimposed 
with the high-resolution structure using the program SUPCOMB. All the SAXS programs 
and calculation modules are included in the ATSAS programs package 61. 
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